Menovo

Zhejiang Menovo Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical enterprise focused on the research, development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates, and finished dosage forms. The company has established itself as a key global supplier in therapeutic areas such as cardiovascular, central nervous system, and gastrointestinal health, with a particular strength in the "Sartan" and "Pril" classes of antihypertensives. Beyond its own product portfolio, Menovo operates as a significant CDMO partner for major multinational pharmaceutical companies, leveraging its advanced chemical synthesis capabilities and GMP-compliant facilities. Headquartered in Ningbo, the company maintains multiple production bases across China and exports its products to regulated markets including Europe and North America. Menovo is publicly traded on the Shanghai Stock Exchange and continues to expand its footprint in both the generic and innovative drug sectors.